1.
Braz. j. microbiol
;
45(2): 559-562, Apr.-June 2014.
Article
in English
| LILACS
| ID: lil-723110
ABSTRACT
Ochrobactrum anthropi infection in newborn patients is rare, and the treatment is challenging because of its widespread and unpredictable resistance to antimicrobial agents and discrepancies between in vitro susceptibility and in vivo efficacy. We report the clinical and microbiological characteristics of Ochrobactrum anthropi bacteremia in a preterm patient.